Compare Canopy Growth Corp (CGC) vs Newmont Corporation (NEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Canopy Growth Corp vs Newmont Corporation — how do they compare? Canopy Growth Corp trades at $1.04 (market cap $421.10M), while Newmont Corporation trades at $118.15 (market cap $123.50B). The key difference: Newmont Corporation is far larger — about 293.3× Canopy Growth Corp's market cap, and Newmont Corporation pays a 0.89% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.
| CGC | NEM | |
|---|---|---|
Market Cap | $421.10M | $123.50B |
Sector | Health | Basic Materials |
52-Week High | $1.92 | $131.95 |
52-Week Low | $0.86 | $67.38 |
Enterprise Value | $378.55M | $120.09B |
Dividend Yield | — | 0.89% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $1.02, up 7.13% with a bullish technical signal. The company reported Q1 fiscal 2027 revenue growth of 13% to C$81.2 million and narrowed its EBITDA loss. While revenue trends show stabilization after declining from $520M in 2022 to $269M in 2025, the company continues to post significant net losses with a -222.36% margin. The balance sheet shows improvement with debt-to-asset ratio declining from 53.61% in 2023 to 33.13% in 2025.
CGC presents a high-risk opportunity with potential catalysts from cannabis rescheduling and European expansion. The stock trades below book value (P/B 0.86) but faces substantial execution risks amid persistent losses. Analyst sentiment is mixed with 33% buy ratings, reflecting optimism about restructuring progress versus concerns about profitability timeline.
Newmont Corporation (NEM) trades at $119.12, up 1.59% with strong technical momentum as it approaches resistance near $120. The company demonstrates robust fundamentals with Q2 2026 EPS beating expectations at $2.10 versus $2.05 forecast, continuing a trend of earnings outperformance. Revenue growth accelerated to $22.67 billion in 2025 with net income margin expanding to 33.36%. Recent news highlights resolution of Nevada disputes with Barrick Mining and strong gold price environment supporting miner profitability.
Outlook remains positive with analyst consensus price target of $133 representing 11.6% upside potential. Key opportunities include continued gold price strength and operational efficiency gains, while risks involve potential cost inflation and gold price volatility. With 76% analyst buy ratings and improving cash flow trends, NEM appears well-positioned for continued growth in the current commodity cycle.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Canopy Growth Corp
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →About Newmont Corporation
Newmont Corp is primarily a gold producer with operations and/or assets in the United States, Canada, Mexico, Dominican Republic, Peru, Suriname, Argentina, Chile, Australia, and Ghana. It is also engaged in the production of copper, silver, lead and zinc. The company's operations are organized in five geographic regions: North America, South America, Australia, Africa and Nevada.
Read more on NEM →
